Literature DB >> 20555077

Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

V Grégoire1, J-L Lefebvre, L Licitra, E Felip.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20555077     DOI： 10.1093/annonc/mdq185

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  155 in total

1.  Advanced and rapidly progressing head and neck cancer: good palliation following intralesional bleomycin.

Authors:  Keith Ian Quintyne; Shirley Baker; Fintan Wallis; Neville Shine; Rajnish Gupta
Journal:  BMJ Case Rep       Date:  2011-09-19

2.  (18)F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma.

Authors:  Thomas Bird; Sally Barrington; Selvam Thavaraj; Jean-Pierre Jeannon; Andrew Lyons; Richard Oakley; Ricard Simo; Mary Lei; Teresa Guerrero Urbano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-28       Impact factor: 9.236

3.  Is integrated 18F-FDG PET/MRI superior to 18F-FDG PET/CT in the differentiation of incidental tracer uptake in the head and neck area?

Authors:  Benedikt Michael Schaarschmidt; Benedikt Gomez; Christian Buchbender; Johannes Grueneisen; Felix Nensa; Lino Morris Sawicki; Verena Ruhlmann; Axel Wetter; Gerald Antoch; Philipp Heusch
Journal:  Diagn Interv Radiol       Date:  2017 Mar-Apr       Impact factor: 2.630

Review 4.  The prognostic and predictive value of excision repair cross-complementation group 1 (ERCC1) protein in 1288 patients with head and neck squamous cell carcinoma treated with platinum-based therapy: a meta-analysis.

Authors:  Vesna Bišof; Matea Zajc Petranović; Zoran Rakušić; Kristina Ruža Samardžić; Antonio Juretić
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-16       Impact factor: 2.503

5.  Clinical experience on diagnosis and treatment for malignancy originating from the dacryocyst.

Authors:  Li-Juan Zhu; Yu Zhu; Shang-Chen Hao; Pei Huang; Lin-Lin Wang; Xiu-Hong Li; Li-Hong Lian; Ke Zhang
Journal:  Eye (Lond)       Date:  2018-05-30       Impact factor: 3.775

6.  Multidisciplinary clinical approach to the management of head and neck cancer.

Authors:  Patrick J Bradley
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-16       Impact factor: 2.503

Review 7.  Metastatic disease in head & neck oncology.

Authors:  Paolo Pisani; Mario Airoldi; Anastasia Allais; Paolo Aluffi Valletti; Mariapina Battista; Marco Benazzo; Roberto Briatore; Salvatore Cacciola; Salvatore Cocuzza; Andrea Colombo; Bice Conti; Alberto Costanzo; Laura Della Vecchia; Nerina Denaro; Cesare Fantozzi; Danilo Galizia; Massimiliano Garzaro; Ida Genta; Gabriela Alejandra Iasi; Marco Krengli; Vincenzo Landolfo; Giovanni Vittorio Lanza; Mauro Magnano; Maurizio Mancuso; Roberto Maroldi; Laura Masini; Marco Carlo Merlano; Marco Piemonte; Silvia Pisani; Adriele Prina-Mello; Luca Prioglio; Maria Gabriella Rugiu; Felice Scasso; Agostino Serra; Guido Valente; Micol Zannetti; Angelo Zigliani
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-04       Impact factor: 2.124

8.  Oral health and human papillomavirus-associated head and neck squamous cell carcinoma.

Authors:  Angela L Mazul; James M Taylor; Kimon Divaris; Mark C Weissler; Paul Brennan; Devasena Anantharaman; Behnoush Abedi-Ardekani; Andrew F Olshan; Jose P Zevallos
Journal:  Cancer       Date:  2016-08-29       Impact factor: 6.860

Review 9.  Therapeutic exercises for affecting post-treatment swallowing in people treated for advanced-stage head and neck cancers.

Authors:  Alison Perry; Siew Hwa Lee; Susan Cotton; Catriona Kennedy
Journal:  Cochrane Database Syst Rev       Date:  2016-08-26

Review 10.  Recent multidisciplinary approach with molecular targeted drugs for advanced head and neck cancer.

Authors:  Masato Fujii
Journal:  Int J Clin Oncol       Date:  2014-02-28       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.